Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$622.4M
62M shares
52-week range
$7.77 – $32.76
10% from low
Sector
SERVICES-BUSINESS SERVICES, NEC
Exchange
NYSE
CS
Borrow rate
0.46%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $99.9M | $124.8M | $148.7M | $213.2M | $280.9M | $356.3M | $419.8M | $480.6M |
| Cost of revenue | $37.0M | $44.7M | $52.4M | $81.4M | $109.3M | $124.0M | $134.9M | $154.1M |
| Gross profit | $62.9M | $80.1M | $96.3M | $131.8M | $171.6M | $232.3M | $284.9M | $326.5M |
| Gross margin | 63.0% | 64.2% | 64.8% | 61.8% | 61.1% | 65.2% | 67.9% | 67.9% |
| R&D | $14.3M | $18.6M | $22.6M | $52.3M | $91.2M | $112.3M | $117.4M | $121.5M |
| Operating income | −$9.5M | −$15.3M | −$25.7M | −$116.8M | −$176.6M | −$136.5M | −$58.1M | −$6.6M |
| EBITDA | $2.1M | −$5.1M | −$7.6M | −$92.3M | −$145.5M | −$102.9M | −$25.6M | $29.5M |
| Net income | −$15.1M | −$20.3M | −$27.3M | −$118.2M | −$176.1M | −$136.9M | −$58.5M | $2.3M |
| Net margin | -15.1% | -16.3% | -18.4% | -55.4% | -62.7% | -38.4% | -13.9% | 0.5% |
| EPS (diluted) | -8.16 | -1.00 | -0.69 | -2.37 | -3.36 | -2.51 | -1.02 | 0.04 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $515M | $0.40 | $0.23–$0.60 | 9 |
| 2028 | $539M | $0.65 | $0.53–$0.90 | 8 |
| 2029 | $560M | $0.77 | $0.66–$0.85 | 4 |
| 2030 | $539M | $0.92 | $0.89–$0.94 | 2 |
Forward consensus · source: Financial Modeling Prep
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
www.phreesia.comNo one on the platform currently holds PHR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-09-30 | 13,600 | $309.9K |
| Bridgewater Associatesas of 2025-12-31 | 12,805 | $216.7K |
No one on the platform has traded PHR yet.
| $1.5B |
| — |
| NEOGNeogen Corporation | $9.58 | +0.74% | $2.1B | — |
| NVCRNovocure Ltd | $15.43 | +2.52% | $1.8B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 1.4× sales vs its 4.3× historical median P/S.
Fair value ≈ $32.68 · price $10.29 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$PHR is currently trading at 10.09. While the stock has seen high volatility and faces ongoing securities class action attention, institutional interest remains. It is considered a "show me" growth story, with analysts focusing on its ability to maintain margins and scale its healthcare intake platform. Exercise extreme caution and review recent SEC filings before considering exposure.
View on StockTwits ↗$INTC 466% already; congrats 🔆🌿🌟 Checkout $PHR and $RXRX; similar or greater potential. Do your DD and get in. All the best.
View on StockTwits ↗$CPRI $MU $ON $MU1588 % already; congrats 🔆🌿🌟 Checkout $PHR and $$TTD; undervalued now, but can easily double or triple from here; for those who are patient. $RXR X, is generational wealth opportunity for longs.
View on StockTwits ↗$PHR Outstanding article that hits the mark on PHR's current state. So if you want to refresh your PHR insights or learn about PHR from scratch, this is a must read. https://everyticker.com/quote/PHR/analysis/phreesia-s-profitability-inflection-meets-6b-payment-opportunity-nasdaq-phr
View on StockTwits ↗$PHR If this holds $10.00, $15.00 could be the new target.
View on StockTwits ↗$PHR my god keep handing out cheapies! thank you thank you
View on StockTwits ↗$PHR no brainer at this price. easy double from here by end of 2026 if operating momentum continues and that's still using a distressed 10x multiple
View on StockTwits ↗$PHR Ouchy. Guess I will be staying away completely. Stock is so weak
View on StockTwits ↗$PHR - Phreesia Inc - 10Q - Updated Risk Factors 🚨 Peer Alert: Risk-factor words are +2041.1% above peer average (29,847 vs 1,394 across 714 peers). PHR flags rising risks from its financing arm’s dependence on securitization capital, higher card network/interchange fees, new restructuring-driven execution and morale challenges, longer and more volatile sales cycles, intensifying AI-driven competition and regulatory burdens, expanding data security/privacy and identity-theft obligations (highlighting a 2024 ConnectOnCall incident), and restrictive covenants in a new securitization program that could constrain liquidity and operations. #HealthcareTechnology #SecuritizationRisks #AICompetition #DataSecurity #RegulatoryCompliance 🟢 Added 🟠 Removed https://d-risk.ai/PHR/10-Q/2026-05-28
View on StockTwits ↗RECAP 5/28 +Pos Comments: $ZS + Malcolm Ethridge $PUMP + Odeon Capital RECAP 5/28 -Neg Comments: $DLTR - Freedom Broker $CPRX - HC Wainwright $PHR - Piper Sandler
View on StockTwits ↗RECAP 5/28 +Pos Comments: $ZS + Malcolm Ethridge $PUMP + Odeon Capital RECAP 5/28 -Neg Comments: $DLTR - Freedom Broker $CPRX - HC Wainwright $PHR - Piper Sandler Live Breaking trading news www.openoutcrier.com
View on StockTwits ↗$PHR Getting close to a buy point again for me. What an awful performing stock though. Will remain on sidelines until it can regain some strength. Glad I had the sense to sell on the earnings pump
View on StockTwits ↗$PHR Looks like a nice Turn-A-Round story, took some ( 9,65 )
View on StockTwits ↗$PHR Tempted to rebuy down here but it's acting like a shit show again for now
View on StockTwits ↗$PHR is on fire 🔥 The company just delivered a massive +337% earnings surprise, completely crushing expectations. This kind of growth doesn’t go unnoticed — and the market is reacting accordingly. 📈 Technical Analysis (TA): The stock is in a clear bullish trend, trading above key moving averages (MA20 / MA50) Strong volume spike confirms institutional interest Recent breakout above resistance → now acting as support RSI is elevated but not yet in extreme overbought territory → room for continuation 💡 As long as $PHR holds above its breakout level, momentum remains to the upside. Pullbacks could offer buying opportunities. This is what real momentum looks like. #stocks #trading #bullish
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.